From: Visually guided classification trees for analyzing chronic patients
Feature | Description | 5192-6144-7071 | 1000-5192-6144-7071 | 5424-6144-7071 | 1000-5424-6144-7071 | 1000-5192-5424-6144-7071 |
---|---|---|---|---|---|---|
250 | Diabetes mellitus | (1) | (1) | Â | (1) | (1) |
272 | Disorders of lipoid metabolism | Â | Â | Â | (7) | Â |
366 | Cataract | Â | (7) | Â | Â | Â |
401 | Essential hypertension | Â | (3) | (2) | (4) | (3,4,5) |
496 | Chronic obstructive pulmonary disease | (3) | (3) | (3) | (3) | (3) |
724 | Other and unspecified disorders of back | (12) | (6) | Â | Â | Â |
780 | General symptoms | (8) | Â | Â | Â | Â |
A02BC | Proton pump inhibitors | Â | (3,11) | (7,8) | Â | (5,6) |
A03FA | Propulsives | Â | Â | Â | (7) | Â |
A10AE | Insulins and analogues for injection, long-acting | (11) | (5) | (4,5) | Â | Â |
A10BA | Blood glucose lowering drugs, excl. Insulins | (2,4) | (2,4) | (8) | Â | (2) |
A10BD | Combinations of oral blood glucose lowering drugs | (10) | (10) | Â | Â | Â |
B01AB | Heparin group. Antithrombotic agents | Â | Â | Â | Â | (5) |
B01AC | Platelet aggregation inhibitors excl. heparin | Â | Â | (7) | Â | Â |
C03CA | Sulfonamides, plain. High-ceiling diuretics | Â | (9) | (6) | (6) | (7) |
C07AA | Beta blocking agents, non-selective | (6) | Â | Â | Â | Â |
C07AB | Beta blocking agents, selective | Â | Â | (9) | Â | Â |
C08CA | Selective calcium channel blockers with mainly vascular effects. Dihydropyridine derivatives | (13) | Â | (5) | Â | Â |
C09AA | ACE inhibitors, plain | Â | (6) | (3) | Â | (4,6) |
C09BA | ACE inhibitors and diuretics | Â | (7) | Â | Â | (8) |
C10AA | HMG coa reductase inhibitors | Â | (8,9) | (7,9) | Â | Â |
M02AA | Antiinflammatory preparations, non-steroids for topical use | Â | Â | Â | (6) | Â |
M04AA | Preparations inhibiting uric acid production | Â | Â | (5) | Â | Â |
N02BB | Other analgesics and antipyretics. Pyrazolones | Â | (8) | (8,9) | Â | (3,6) |
N02BE | Other analgesics and antipyretics. Anilides | (9) | Â | (6,8) | Â | (6) |
N05AL | Antipsychotics. Benzamides | (2,3) | (2,4) | (1) | (2) | (2) |
N05CD | Hypnotics and sedatives | (5) | Â | Â | (5) | Â |
N06AB | Selective serotonin reuptake inhibitors | Â | Â | Â | Â | (6,7) |
N06AX | Antidepressants | Â | (6) | Â | Â | Â |
N06DA | Antidepressants | Â | Â | (6) | Â | Â |
R01AX | Other nasal preparations | Â | Â | (10) | Â | Â |
R03BB | Anticholinergics | (7) | Â | (4) | Â | (6) |
R05CB | Mucolytics | Â | (5) | (9) | Â | Â |
Age | Â | (14) | (7) | Â | (8) | Â |